Form 8-K - Current report:
SEC Accession No. 0001193125-23-000776
Filing Date
2023-01-03
Accepted
2023-01-03 16:27:35
Documents
12
Period of Report
2022-12-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d426931d8k.htm   iXBRL 8-K 22636
  Complete submission text file 0001193125-23-000776.txt   139478

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA medp-20221231.xsd EX-101.SCH 2849
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE medp-20221231_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE medp-20221231_pre.xml EX-101.PRE 10811
6 EXTRACTED XBRL INSTANCE DOCUMENT d426931d8k_htm.xml XML 3214
Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address 5375 MEDPACE WAY CINCINNATI OH 45227 (513) 579-9911
Medpace Holdings, Inc. (Filer) CIK: 0001668397 (see all company filings)

EIN.: 320434904 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37856 | Film No.: 23502477
SIC: 8731 Services-Commercial Physical & Biological Research